(3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide

C45H68N4O5 — CID 163732307

IUPAC(3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide
SMILESCCCOc1ccccc1CN(Cc1cccc(CN2O[C@@H](CO)[C@@H]([C@H](C)O)[C@H]2C(=O)N[C@@]23CC4C2[C@@H]([C@@H]3C)C4(C)C)c1)[C@@H](CC(C)C)CN1CCCC1
InChIInChI=1S/C45H68N4O5/c1-8-20-53-37-17-10-9-16-34(37)26-48(35(21-29(2)3)27-47-18-11-12-19-47)24-32-14-13-15-33(22-32)25-49-42(39(31(5)51)38(28-50)54-49)43(52)46-45-23-36-41(45)40(30(45)4)44(36,6)7/h9-10,13-17,22,29-31,35-36,38-42,50-51H,8,11-12,18-21,23-28H2,1-7H3,(H,46,52)/t30-,31-,35-,36?,38-,39+,40+,41?,42-,45+/m0/s1
InChIKeyLAQRAWAMCKIRRY-HEPQCMLQSA-N
MW745.06 g/mol
LogP6.26
Rot. Bonds18

About (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide

(3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide (PubChem CID 163732307) has the molecular formula C45H68N4O5 and a molecular weight of 745.06 g/mol. Its IUPAC name is (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide.

Molecular Properties

Compound Name(3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide
PubChem CID163732307
Molecular FormulaC45H68N4O5
Molecular Weight745.06 g/mol
Exact Mass744.52
IUPAC Name(3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide
SMILESCCCOc1ccccc1CN(Cc1cccc(CN2O[C@@H](CO)[C@@H]([C@H](C)O)[C@H]2C(=O)N[C@@]23CC4C2[C@@H]([C@@H]3C)C4(C)C)c1)[C@@H](CC(C)C)CN1CCCC1
InChIInChI=1S/C45H68N4O5/c1-8-20-53-37-17-10-9-16-34(37)26-48(35(21-29(2)3)27-47-18-11-12-19-47)24-32-14-13-15-33(22-32)25-49-42(39(31(5)51)38(28-50)54-49)43(52)46-45-23-36-41(45)40(30(45)4)44(36,6)7/h9-10,13-17,22,29-31,35-36,38-42,50-51H,8,11-12,18-21,23-28H2,1-7H3,(H,46,52)/t30-,31-,35-,36?,38-,39+,40+,41?,42-,45+/m0/s1
InChIKeyLAQRAWAMCKIRRY-HEPQCMLQSA-N
XLogP6.26
TPSA97.74 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds18
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500745.06
LogP ≤ 56.26
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide?
The IUPAC name of (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide (CID 163732307) is (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide.
What is the SMILES notation for (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide?
The canonical SMILES for (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide is CCCOc1ccccc1CN(Cc1cccc(CN2O[C@@H](CO)[C@@H]([C@H](C)O)[C@H]2C(=O)N[C@@]23CC4C2[C@@H]([C@@H]3C)C4(C)C)c1)[C@@H](CC(C)C)CN1CCCC1.
What is the InChIKey of (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide?
The InChIKey is LAQRAWAMCKIRRY-HEPQCMLQSA-N. The full InChI is InChI=1S/C45H68N4O5/c1-8-20-53-37-17-10-9-16-34(37)26-48(35(21-29(2)3)27-47-18-11-12-19-47)24-32-14-13-15-33(22-32)25-49-42(39(31(5)51)38(28-50)54-49)43(52)46-45-23-36-41(45)40(30(45)4)44(36,6)7/h9-10,13-17,22,29-31,35-36,38-42,50-51H,8,11-12,18-21,23-28H2,1-7H3,(H,46,52)/t30-,31-,35-,36?,38-,39+,40+,41?,42-,45+/m0/s1.
What are the key properties of (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide?
(3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide has a molecular weight of 745.06 g/mol, XLogP of 6.26, 18 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,4R,5R)-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[[[(2S)-4-methyl-1-pyrrolidin-1-ylpentan-2-yl]-[(2-propoxyphenyl)methyl]amino]methyl]phenyl]methyl]-N-[(1R,2S,3R,5S)-2,4,4-trimethyl-1-tricyclo[3.1.1.03,6]heptanyl]-1,2-oxazolidine-3-carboxamide is sourced from PubChem (CID 163732307), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).